Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
In-Vivo Science is a Japan-based life science company that develops and supplies immunodeficient and humanized mouse models used in drug discovery, preclinical testing, regenerative medicine research, and basic medical research. Its core offering centers on NOG mice and next-generation genetically modified NOG-derived strains designed to support human cell engraftment, immune-system reconstitution, antibody evaluation, and disease modeling. The company also provides specialized models such as humanized mice, FcResolv NOG strains, IL-15 and IL-6 transgenic variants, and TK-NOG chimeric liver mice for pharmacology, toxicology, and infection-related studies. Rather than advancing proprietary therapeutics, In-Vivo Science operates as a preclinical platform and research-enabling supplier serving biomedical researchers and drug developers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on In-Vivo Science.